Literature DB >> 22949563

Effect of a centralized prescription network on inappropriate prescriptions for opioid analgesics and benzodiazepines.

Colin R Dormuth1, Tarita A Miller, Anjie Huang, Muhammad M Mamdani, David N Juurlink.   

Abstract

BACKGROUND: Opioid analgesics and benzodiazepines are often misused in clinical practice. We determined whether implementation of a centralized prescription network offering real-time access to patient-level data on filled prescriptions (PharmaNet) reduced the number of potentially inappropriate prescriptions for opioids and benzodiazepines.
METHODS: We conducted a time series analysis using prescription records between Jan. 1, 1993, and Dec. 31, 1997, for residents of the province of British Columbia who were receiving social assistance or were 65 years or older. We calculated monthly percentages of filled prescriptions for an opioid or a benzodiazepine that were deemed inappropriate (those issued by a different physician and dispensed at a different pharmacy within 7 days after a filled prescription of at least 30 tablets of the same drug).
RESULTS: Within 6 months after implementation of PharmaNet in July 1995, we observed a relative reduction in inappropriate filled prescriptions for opioids of 32.8% (95% confidence interval [CI] 31.0%-34.7%) among patients receiving social assistance; inappropriate filled prescriptions for benzodiazepines decreased by 48.6% (95% CI 43.2%-53.1%). Similar and statistically significant reductions were observed among residents 65 years or older.
INTERPRETATION: The implementation of a centralized prescription network was associated with a dramatic reduction in inappropriate filled prescriptions for opioids and benzodiazepines.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22949563      PMCID: PMC3494359          DOI: 10.1503/cmaj.120465

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  7 in total

1.  Use of electronic medical records by ambulatory care providers: United States, 2006.

Authors:  Esther Hing; Margaret J Hall; Jill J Ashman
Journal:  Natl Health Stat Report       Date:  2010-04-30

2.  Facing up to the prescription opioid crisis.

Authors:  Irfan A Dhalla; Navindra Persaud; David N Juurlink
Journal:  BMJ       Date:  2011-08-23

3.  Use of other opioids during methadone therapy: a population-based study.

Authors:  Paul Kurdyak; Tara Gomes; Zhan Yao; Muhammad M Mamdani; Chelsea Hellings; Benedikt Fischer; Jürgen Rehm; Ahmed M Bayoumi; David N Juurlink
Journal:  Addiction       Date:  2012-01-18       Impact factor: 6.526

4.  Medication administration quality and health information technology: a national study of US hospitals.

Authors:  Ajit Appari; Emily K Carian; M Eric Johnson; Denise L Anthony
Journal:  J Am Med Inform Assoc       Date:  2011-10-28       Impact factor: 4.497

5.  Do prescription monitoring programs impact state trends in opioid abuse/misuse?

Authors:  Liza M Reifler; Danna Droz; J Elise Bailey; Sidney H Schnoll; Reginald Fant; Richard C Dart; Becki Bucher Bartelson
Journal:  Pain Med       Date:  2012-02-02       Impact factor: 3.750

6.  Effect of periodic letters on evidence-based drug therapy on prescribing behaviour: a randomized trial.

Authors:  Colin R Dormuth; Malcolm Maclure; Kenneth Bassett; Ciprian Jauca; Carl Whiteside; James M Wright
Journal:  CMAJ       Date:  2004-10-26       Impact factor: 8.262

7.  Impact of two sequential drug cost-sharing policies on the use of inhaled medications in older patients with chronic obstructive pulmonary disease or asthma.

Authors:  Colin R Dormuth; Robert J Glynn; Peter Neumann; Malcolm Maclure; Alan M Brookhart; Sebastian Schneeweiss
Journal:  Clin Ther       Date:  2006-06       Impact factor: 3.393

  7 in total
  24 in total

1.  Canadian community pharmacists' use of digital health technologies in practice.

Authors:  Valerie Leung; Sukirtha Tharmalingam; Janet Cooper; Maureen Charlebois
Journal:  Can Pharm J (Ott)       Date:  2016-01

Review 2.  Benzodiazepine Use, Misuse, and Harm at the Population Level in Canada: A Comprehensive Narrative Review of Data and Developments Since 1995.

Authors:  Yoko Murphy; Emily Wilson; Elliot M Goldner; Benedikt Fischer
Journal:  Clin Drug Investig       Date:  2016-07       Impact factor: 2.859

Review 3.  What we know, and don't know, about the impact of state policy and systems-level interventions on prescription drug overdose.

Authors:  Tamara M Haegerich; Leonard J Paulozzi; Brian J Manns; Christopher M Jones
Journal:  Drug Alcohol Depend       Date:  2014-10-14       Impact factor: 4.492

Review 4.  Harmonizing post-market surveillance of prescription drug misuse: a systematic review of observational studies using routinely collected data (2000-2013).

Authors:  Bianca Blanch; Nicholas A Buckley; Leigh Mellish; Andrew H Dawson; Paul S Haber; Sallie-Anne Pearson
Journal:  Drug Saf       Date:  2015-06       Impact factor: 5.606

5.  The use of a prescription drug monitoring program to develop algorithms to identify providers with unusual prescribing practices for controlled substances.

Authors:  Christopher Ringwalt; Sharon Schiro; Meghan Shanahan; Scott Proescholdbell; Harold Meder; Anna Austin; Nidhi Sachdeva
Journal:  J Prim Prev       Date:  2015-10

Review 6.  Opioids for low back pain.

Authors:  Richard A Deyo; Michael Von Korff; David Duhrkoop
Journal:  BMJ       Date:  2015-01-05

7.  Real-time access to prescription drug monitoring databases.

Authors:  Barth Wilsey; Hannah Prasad
Journal:  CMAJ       Date:  2012-09-24       Impact factor: 8.262

8.  Prescription drug monitoring and dispensing of prescription opioids.

Authors:  Joanne E Brady; Hannah Wunsch; Charles DiMaggio; Barbara H Lang; James Giglio; Guohua Li
Journal:  Public Health Rep       Date:  2014 Mar-Apr       Impact factor: 2.792

9.  Toward better prescription drug surveillance in Canada.

Authors:  Kate Smolina; Nav Persaud; Steven G Morgan
Journal:  CMAJ       Date:  2016-05-02       Impact factor: 8.262

10.  Impact of legislation and a prescription monitoring program on the prevalence of potentially inappropriate prescriptions for monitored drugs in Ontario: a time series analysis.

Authors:  Tara Gomes; David Juurlink; Zhan Yao; Ximena Camacho; J Michael Paterson; Samantha Singh; Irfan Dhalla; Beth Sproule; Muhammad Mamdani
Journal:  CMAJ Open       Date:  2014-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.